115 related articles for article (PubMed ID: 2909747)
1. Structure-activity relationships among methoctramine-related polymethylene tetraamines. Chain-length and substituent effects on M-2 muscarinic receptor blocking activity.
Melchiorre C; Quaglia W; Picchio MT; Giardinà D; Brasili L; Angeli P
J Med Chem; 1989 Jan; 32(1):79-84. PubMed ID: 2909747
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships among methoctramine-related polymethylene tetraamines. 3. Effect of the four nitrogens on M2 muscarinic blocking activity as revealed by symmetrical and unsymmetrical polyamines.
Quaglia W; Giardinà D; Marucci G; Melchiorre C; Minarini A; Tumiatti V
Farmaco; 1991 Mar; 46(3):417-34. PubMed ID: 1892500
[TBL] [Abstract][Full Text] [Related]
3. Further investigation on methoctramine-related tetraamines: effects of terminal N-substitution and of chain length separating the four nitrogens on M2 muscarinic receptor blocking activity.
Minarini A; Budriesi R; Chiarini A; Melchiorre C; Tumiatti V
Farmaco; 1991 Oct; 46(10):1167-78. PubMed ID: 1815579
[TBL] [Abstract][Full Text] [Related]
4. Methoctramine-related polymethylene tetraamines. 4. Chirality effect on M2 muscarinic receptor blocking activity.
Giardinà D; Marrazzo A; Marucci G; Piloni MG; Quaglia W
Farmaco; 1991; 46(7-8):861-72. PubMed ID: 1793471
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists.
Rosini M; Budriesi R; Bixel MG; Bolognesi ML; Chiarini A; Hucho F; Krogsgaard-Larsen P; Mellor IR; Minarini A; Tumiatti V; Usherwood PN; Melchiorre C
J Med Chem; 1999 Dec; 42(25):5212-23. PubMed ID: 10602706
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 2. Role of polymethylene chain lengths separating amine functions and of substituents on the terminal nitrogen atoms.
Rosini M; Bixel MG; Marucci G; Budriesi R; Krauss M; Bolognesi ML; Minarini A; Tumiatti V; Hucho F; Melchiorre C
J Med Chem; 2002 Apr; 45(9):1860-78. PubMed ID: 11960498
[TBL] [Abstract][Full Text] [Related]
7. Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors.
Melchiorre C; Cassinelli A; Quaglia W
J Med Chem; 1987 Jan; 30(1):201-4. PubMed ID: 3806594
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines.
Minarini A; Bolognesi ML; Budriesi R; Canossa M; Chiarini A; Spampinato S; Melchiorre C
J Med Chem; 1994 Sep; 37(20):3363-72. PubMed ID: 7932564
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties.
Tumiatti V; Minarini A; Milelli A; Rosini M; Buccioni M; Marucci G; Ghelardini C; Bellucci C; Melchiorre C
Bioorg Med Chem; 2007 Mar; 15(6):2312-21. PubMed ID: 17276075
[TBL] [Abstract][Full Text] [Related]
10. Polymethylene tetraamines as muscarinic receptor probes.
Melchiorre C; Minarini A; Angeli P; Giardinà D; Gulini U; Quaglia W
Trends Pharmacol Sci; 1989 Dec; Suppl():55-9. PubMed ID: 2694524
[TBL] [Abstract][Full Text] [Related]
11. Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine.
Melchiorre C; Angeli P; Lambrecht G; Mutschler E; Picchio MT; Wess J
Eur J Pharmacol; 1987 Dec; 144(2):117-24. PubMed ID: 3436364
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure.
Bolognesi ML; Bixel MG; Marucci G; Bartolini M; Krauss M; Angeli P; Antonello A; Rosini M; Tumiatti V; Hucho F; Melchiorre C
J Med Chem; 2002 Jul; 45(15):3286-95. PubMed ID: 12109912
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of tripitramine, a polymethylene tetraamine displaying high selectivity and affinity for muscarinic M2 receptors.
Chiarini A; Budriesi R; Bolognesi ML; Minarini A; Melchiorre C
Br J Pharmacol; 1995 Apr; 114(7):1507-17. PubMed ID: 7606355
[TBL] [Abstract][Full Text] [Related]
14. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
[TBL] [Abstract][Full Text] [Related]
15. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
[TBL] [Abstract][Full Text] [Related]
16. The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists.
Melchiorre C; Minarini A; Budriesi R; Chiarini A; Spampinato S; Tumiatti V
Life Sci; 1995; 56(11-12):837-44. PubMed ID: 10188783
[TBL] [Abstract][Full Text] [Related]
17. Selective blockade in vivo of cardiac muscarinic M2 receptors by a polymethylene tetramine, BHC-9C.
Wess J; Lambrecht G; Mutschler E; Melchiorre C; Angeli P
Eur J Pharmacol; 1987 Oct; 142(3):475-8. PubMed ID: 3428357
[TBL] [Abstract][Full Text] [Related]
18. Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro.
Eglen RM; Harris GC
Br J Pharmacol; 1993 Aug; 109(4):946-52. PubMed ID: 8401947
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activators.
Melchiorre C; Bolognesi ML; Budriesi R; Ghelardini C; Chiarini A; Minarini A; Rosini M; Tumiatti V; Wade EJ
J Med Chem; 2001 Nov; 44(24):4035-8. PubMed ID: 11708906
[TBL] [Abstract][Full Text] [Related]
20. The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro.
Eglen RM; Montgomery WW; Dainty IA; Dubuque LK; Whiting RL
Br J Pharmacol; 1988 Dec; 95(4):1031-8. PubMed ID: 3219478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
